Back to discover
Drug
Henagliflozin
Late-stage clinical developmentClassSodium/glucose cotransporter 2 inhibitor
5
Active clinical trials
Sodium/glucose cotransporter 2
Primary target
Latest activity
betaRecent clinical, regulatory, research and industry developments relating to this drug.
Clinical trial2025-12-31Primary completion · ClinicalTrials.gov
Clinical trial2025-12-31Primary completion · ClinicalTrials.gov
Clinical trial2025-12-19Results expected Q4 2028 · ClinicalTrials.gov
Clinical trial2025-10-01Completed · ClinicalTrials.gov
Clinical trial2025-06-30Completed · ClinicalTrials.gov
Clinical trial2025-06-18Results expected Q4 2027 · ClinicalTrials.gov
Clinical trial2025-01-07Results expected Q4 2026 · ClinicalTrials.gov
Henagliflozin Delays the Progress of Diabetic Nephropathy Via Regulates Gut-Renal Axis
Clinical trial2024-12-31Primary completion · ClinicalTrials.gov
Clinical trial2024-10-30Completed · ClinicalTrials.gov
Clinical trial2024-07-31Primary completion · ClinicalTrials.gov
Clinical trial2024-06-07Results expected Q4 2026 · ClinicalTrials.gov
Clinical trial2024-01-22Results expected Q4 2026 · ClinicalTrials.gov
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Canonical name
Henagliflozin
RxNorm CUI
1904202
ChEMBL ID
CHEMBL4297431
UNII
21P2M98388
Primary mechanism
Sodium/glucose cotransporter 2 inhibitor
Pharmacology & targets
Known molecular targets and mechanisms supported by curated pharmacology databases.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Development programme
CLINICALTRIALS.GOV · LIVE REGISTRY13
registered trials across all phases
LATEST COMPLETION 2025
5
Active studies
5
Recruiting
13
Late-stage (III+)
3
Completed
5
Discontinued
PHASE DISTRIBUTIONn = 13
Phase 31Phase 47Phase N / A5
Late-stage studies
Phase III+ trials still open or recently active — where late-stage evidence is being generated.
Not yet recruitingPH IV
Not yet recruitingPH IV
Not yet recruitingPH IV
Not yet recruitingPH IV
Recent completions
Trials that read out recently, adding to the completed evidence base.
References & data sources
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- ClinicalTrials.gov — clinical trials